Latest Report Details Of Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016


“The Report Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

GlobalData’s clinical trial report, Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H2, 2016″ provides an overview of Metastatic Renal Cell Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Renal Cell Carcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at :


– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Reasons to buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Follow us on LinkedIn:

Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 12

2 Introduction 13

2.1 Catalyst 13

2.2 Related Reports 14

2.3 Upcoming Related Reports 14

3 Disease Overview 15

3.1 Etiology 15

3.1.1 Viral Lifecycle 15

3.2 Pathophysiology 18

3.3 Staging and Symptoms 19

3.3.1 Primary or Acute Infection 19

3.3.2 Chronic Infection 20

3.3.3 Advanced Infection/AIDS 20

3.4 Prognosis 22

3.5 Quality of Life 22

4 Disease Management 24

4.1 Diagnosis and Treatment Overview 24

4.1.1 Screening and Diagnosis 24

4.1.2 Treatment Guidelines and Leading Prescribed Drugs 25

4.1.3 Clinical Practice 27

4.2 US 37

4.2.1 Screening and Diagnosis 39

4.2.2 Clinical Practice 40

5 Competitive Assessment 42

5.1 Overview 42

5.2 Product Profiles – Major Brands, Single-Tablet Regimens (STRs) 45

5.2.1 Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) 45

5.2.2 Complera (emtricitabine/TDF/rilpivirine) 51

5.2.3 Stribild (elvitegravir/cobicistat/TDF/emtricitabine) 58

5.2.4 Triumeq (dolutegravir/abacavir/lamivudine) 66

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074